FDG-PET/CT performances to detect systemic sarcoidosis in patients from a general hospital in Europe

Conclusions: Our retrospective study shows that FDG PET/CT examination is a reliable method to detect systemic sarcoidosis (high sensibility, specificity, PPV, NPV and accuracy). However further evaluation of cost effectiveness of this examination, and a more comprehensive understanding on which patients would benefit from this intervention are warranted.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Outcomes/Infectious Disease/Pulmonary Posters Source Type: research

Related Links:

Researchers have developed a quicker, better and cheaper way than mammograms to detect breast cancer: a laser scanner that can find tumors in 15 seconds.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Speakers at the local government conference today called for a boycott of the government’s controversial plan to introduce an accreditation system for children and family social workers. Malcolm Jarvis of Salford moved a motion to “Say no to National Assessment and Accreditation”, telling delegates that the work done by social workers in children’s services is “absolutely crucial to the welfare of children and families”. Yet, at a time when children’s services are experiencing a funding shortfall of £600m, the government is giving £23m to private companies – inclu...
Source: UNISON Health care news - Category: UK Health Authors: Tags: Article Source Type: news
Condition:   Tuberculosis Intervention:   Sponsors:   University of Virginia;   National Institute of Allergy and Infectious Diseases (NIAID);   Scientific Center for Family Health and Human Reproduction Problems, Russia;   Kilimanjaro Christian Medical Centre, Tanzania;   Haydom Lutheran Hospital;   Mbarara University of Science a nd Technology;   International Centre for Diarrhoeal Disease Research, Bangladesh;   University of Florida Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Colorectal Neoplasm;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasm;   Rectal Diseases;   Colonic Diseases;   Intestinal Disease;   Gastrointestinal Disease;   Digestive System Disease Intervention:   Dietary Supplement: Ocoxin-Viusid Sponsor:   Catalysis SL Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pancreatic Adenocarcinoma Intervention:   Drug: chemotherapy: TS-1, Leucovorin and Gemcitabine Sponsors:   National Health Research Institutes, Taiwan;   National Taiwan University Hospital;   China Medical University Hospital;   Kaohsiung Medical University;   Chang Gung Memorial Hospital;   National Cheng-Kung University Hospital Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: EBUS-TBNA is a safe and efficacious procedure which can be performed using conscious sedation with high yields. It can be used for the staging of malignancies as well as for the diagnosis of inflammatory and infectious conditions such as sarcoidosis and TB.
Source: Annals of Thoracic Medicine - Category: Respiratory Medicine Authors: Source Type: research
Conclusions: EBUS-TBNA is highly accurate (diagnostic yield 92%) and safe procedure for diagnosing mediastinal lymphadenopathy. In our experience, granulomatous lymphadenitis was most common with TB as the main etiology.
Source: Lung India - Category: Respiratory Medicine Authors: Source Type: research
Conclusions Lung biopsy through medical thoracoscopy is a safe, effective and viable procedure for the diagnosis of diffuse parenchymal lung diseases.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
ConclusionThe operation risk of EBUS‐TBNA is relatively small. In diseases complicated by mediastinal lymphadenectasis, malignant diseases are most, and benign diseases mainly are granulomatous. EBUS‐TBNA is a valuable diagnostic technique in patients with mediastinal lymphadenectasis whose diagnosis have not been determined.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLE Source Type: research
ConclusionThe operation risk of EBUS‐TBNA is relatively small. In the diseases complicated by mediastinal lymphadenectasis, malignant diseases are most, and benign diseases mainly are granulomatous. EBUS‐TBNA is a valuablediagnostic technique in patients with mediastinal lymphadenectasis whose diagnosis have not been determined.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Original Article Source Type: research
More News: Adenocarcinoma | Brain | Eyes | Infectious Diseases | Neurology | Nuclear Medicine | PET Scan | Sarcoidosis | Study | Tuberculosis